A sugar switch for anti-inflammatory antibodies

Royston Jefferis

doi:10.1038/nbt1006-1230

A sugar switch for anti-inflammatory antibodies

Royston Jefferis

Immunology and Immunotherapy

Research output: Contribution to journal › Editorial

18 Citations (Scopus)

Abstract

The finding that antibody sialylation can suppress inflammation provides new opportunities for drug development.

Original language	English
Pages (from-to)	1230-1231
Number of pages	2
Journal	Nature Biotechnology
Volume	24
Issue number	10
DOIs	https://doi.org/10.1038/nbt1006-1230
Publication status	Published - 1 Oct 2006

Access to Document

10.1038/nbt1006-1230

Cite this

@article{325f08d72f524b5b99954f743980b73d,

title = "A sugar switch for anti-inflammatory antibodies",

abstract = "The finding that antibody sialylation can suppress inflammation provides new opportunities for drug development.",

author = "Royston Jefferis",

year = "2006",

month = oct,

day = "1",

doi = "10.1038/nbt1006-1230",

language = "English",

volume = "24",

pages = "1230--1231",

journal = "Nature Biotechnology",

publisher = "Nature Publishing Group",

number = "10",

}

TY - JOUR

T1 - A sugar switch for anti-inflammatory antibodies

AU - Jefferis, Royston

PY - 2006/10/1

Y1 - 2006/10/1

N2 - The finding that antibody sialylation can suppress inflammation provides new opportunities for drug development.

AB - The finding that antibody sialylation can suppress inflammation provides new opportunities for drug development.

U2 - 10.1038/nbt1006-1230

DO - 10.1038/nbt1006-1230

M3 - Editorial

C2 - 17033662

VL - 24

SP - 1230

EP - 1231

JO - Nature Biotechnology

JF - Nature Biotechnology

IS - 10

ER -

A sugar switch for anti-inflammatory antibodies

Abstract

Access to Document

Fingerprint

Cite this